Prof. Sylviane Muller awarded prestigious Legion d’honneur.’

ImmuPharma PLC (LSE:IMM; Euronext Growth Brussels: ALIMM),  the specialist drug discovery and development company, is delighted to announce that Prof. Sylviane Muller, inventor of Lupuzor™ and P140 technology and a key collaboration partner, has been awarded the highly prestigious Legion d’honneur Award.

The ‘Remise des insignes d’officier de la Légion d’honneur’ was presented to Prof. Muller at an
awards ceremony yesterday evening at l’Institut de Science et d’Ingénierie Supramoléculaires (ISIS) in Strasbourg.

The ‘Legion of Honor’ is the highest French decoration and one of the most famous in the world. For two centuries, being established in 1802 by Napoleon Bonaparte, it has been retained by all later French governments and presented on behalf of the Head of State to reward the most deserving citizens in all fields of activity.

Tim McCarthy (CEO and Chairman), Prof. Sylviane Muller and Tim Franklin (Chief Operating Officer)

Commenting on this award, Tim McCarthy, CEO and Chairman of ImmuPharma, said:

“On behalf of the Board and the whole team at ImmuPharma, we congratulate Prof. Muller on this highly prestigious award, which is highly deserving, in recognition of her many years of work and commitment to understanding the complexities of the human immune system. We are hugely honoured to be working in partnership with Prof. Muller on Lupuzor™ and the P140 platform, in which her passion and drive and collaborative approach has been an invaluable contribution to our clinical team, as we move closer to offering therapeutic drugs, initially in lupus, which will be of enormous benefit to patients.”

To download this announcement click here